medigraphic.com
ISSN 0016-3813 (Print)

2007, Number 1

<< Back Next >>

Gac Med Mex 2007; 143 (1)

Síndrome del espectro autista. Importancia del diagnóstico temprano

Limon A

Language: Spanish
References: 54
Page: 73-78
PDF size: 54.22 Kb.


ABSTRACT

Autism, currently known as Autism Spectrum Disorder (ASD), is a lifelong neuropsychiatric disorder that starts before three years of age. The behavioral and cognitive symptoms seem to be caused by an abnormal synaptic connectivity that leads to deficits in the ability to filter sensory information. Poor filtering seems to constitute a barrier for the integration and processing of neuronal information. Because ASD is not a neurodegenerative disorder, under appropriate conditions, symptoms usually improve over time, probably because the autistic person learns to filter sensory information by alternative neuronal routes. This allows him/her to have a better understanding of the surrounding environment and in turn facilitates learning. Early intervention on children identified before age 2 notably improves prognosis. Currently, ASD can be detected in boys and girls when they are about 18 months old. However, parents and autism experts can observe symptoms before that age. The participation of the health system in order to prepare parents, pediatricians, and caregivers is highly important and leads to significant improvements in the quality of life of autistic individuals and of caregivers.


REFERENCES

  1. Bertrand J, Mars A, Boyle C, Bove F, Yeargin-Allsopp M, Decoufle P. Prevalence of Autism in a United States Population: The Brick Township, New Jersey, Investigation. Pediatrics 2001;108:1155-1161.

  2. Croen L, Grether J, Hoogstrate J, Selvin S. The changing prevalence of autism in California. J Autism Dev Disord 2002;32:207-215.

  3. Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C. Prevalence of autism in a US metropolitan area. JAMA 2003;289:49-55.

  4. Larsson HJ, Eaton WW, Madsen KM, Vestergaard M, Olesen AV, Agerbo E, et al. Risk Factors for Autism: Perinatal Factors, Parental Psychiatric History, and Socioeconomic Status. Am J Epidem 2005; 161, DOI: 10.1093/aje/kwi123.

  5. Center for Disease Control and Prevention. Department of Health and Human Services of Unites States. Disponible en: http://www.cdc.gov/ncbddd/dd/aic/states/index.htm. Revisado Enero 15, 2006.

  6. Frith U. Autism: Explaining the Enigma. Blackwell, Oxford, 1989.

  7. World Health Organization. The tenth revision of the international classification of diseases and related health problems (ICD-10) Génova: WHO, 1992.

  8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) Washington, DC: American Psychiatric Association, 1994.

  9. Berney TP. Autism an evolving concept. Br Journal Psych 2000;176:20-25.

  10. Minshew NJ, Payton JB. New perspectives in autism. Part I. The clinical spectrum of autism. Curr Probl Pediatric 1988;10:561-610.

  11. Allen DA. Autistic spectrum disorders: clinical presentation in preschool children J Child Neurol 1988;3 Suppl:S48-S56.

  12. Szatmari P. The validity of autistic spectrum disorders: a literature review. J Autism Dev Disord 1992;22:583-600.

  13. NICHD National Institute of Child Health and Human Development. National Institute of Health of Unites States. Autism Facts Publication 01-4962. Disponible en: http://www.nichd.nih.gov/autism

  14. International Molecular Genetics Study of Autism Consortium. A full genome screen for autism with evidence for linkage to a region on chromosome 7q. Hum Mol Genet 1998;7:571-578.

  15. International Molecular Genetics Study of Autism Consortium. Further characterization of the autism susceptibility locus AUTS1 on chromosome 7q. Hum Mol Genet 2001;10:973-982.

  16. Lauritsen MB, Ewald H. The genetics of autism. Acta Psychiatr Scand 2001;103:411-427.

  17. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, et al. Ileallymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998;351:637-641.

  18. Wakefield AJ. MMR vaccination and autism. Lancet 1999;354:949-950.

  19. Torrente F, Ashwood P, Day R, Machado N, Furlano RI, Anthony A, Davies SE, et al. Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry 2002;7:375-382.

  20. Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, et al. A population-based study of measles, mumps, and rubella vaccination and autism. New England J Med 2002;347:1477-1482.

  21. Smeeth L, Cook C, Fombonne E, Heavey L, Rodrigues LC, Smith PG, et al. MMR vaccination and pervasive developmental disorders: A case–control study. Lancet 2004;364:963-969.

  22. Honda H, Shimizu Y, Rutter M. No effect of MMR withdrawal on the incidence of autism: a total population study. J Child Psychol Psychiatry 2005;46:572-579.

  23. Horvath K, Perman JA. Autistic disorder and gastrointestinal disease. Curr Opin Pediatr 2002;14:583-587.

  24. White JF. Intestinal Pathophysiology in Autism. Exp Biol Med 2003;228:639-649.

  25. Vojdani A, Campbell AW, Anyanwu E, Kashanian A, Bock K, Vojdani E. Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. J Neuroimmunol 2002;129:168-177.

  26. Murch S. Diet, immunity, and autistic spectrum disorders. J Pediatr 2005;146:582-584.

  27. Ozonoff S, Pennington B, Rogers SJ. Executive function deficits in highfunctioning autistic individuals: relationship to theory of mind. J Child Psychol Psychiatry 1991;32:1081-1105.

  28. Baron-Cohen S, Leslie AM, Frith U. Does the autistic child have a ‘theory of mind’? Cognition 1985;21:37-46.

  29. Baron-Cohen S. The extreme male brain theory of autism. Trends Cogn Sci 2002;6:248-254.

  30. Hashimoto T, Tayama M, Murakawa K, Yoshimoto T, Miyazaki M, Harada M, et al. Development of the brainstem and cerebellum in autistic patients. J Autism Devel Disord 1995;25:1-18.

  31. Aylward EH, Minshew NJ, Goldstein G, Honeycutt NA, Augustine AM, Yates K, et al. MRI volumes of amygdala and hippocampus in non-mentally retarded autistic adolescents and adults. Neurology 1999;53:2145-2150.

  32. Sparks BF, Friedman SD, Shaw DW, Aylward EH, Echelard D, Artru AA, et al. Brain structural abnormalities in young children with autism spectrum disorder. Neurology 2002;59:184-192.

  33. Aylward EH, Minshew NJ, Field K, Sparks BF, Singh N. Effects of age on brain volume and head circumference in autism. Neurology 2002;59:175-183.

  34. Belmonte MK, Cook EH Jr, Anderson GM, Rubenstein JL, Greenough WT, Beckel-Mitchener A, et al. Autism as a disorder of Neural Information Processing: Directions for Research and Targets for Therapy. Mol Psychiatry, 2004;9:646-663.

  35. Belmonte MK, Allen G, Beckel-Mitchener A, Boulanger LM, Carper RA, Webb SJ. Autism and Abnormal Development of Brain Connectivity. J Neurosci 2004;24:9228-9231.

  36. Courchesne E. Abnormal early brain development in autism. Mol Psychiatry 2002;7:21-23.

  37. Courchesne E, Carper R, Akshoomoff N. Evidence of brain overgrowth in the first year of life in autism. JAMA 2003;290:337-344.

  38. Courchesne E, Pierce K. Brain overgrowth in autism during a critical time in development: implications for frontal pyramidal neuron and interneuron development and connectivity. J Devl Neurosci 2005;23:153-170.

  39. Lee M, Martin-Ruiz C, Graham A, Court J, Jaros E, Perry R, et al. Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain 2002;125:1483-1495.

  40. Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC, et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003;34:27-29.

  41. Wray J, Silove N, Knott H. Language disorders and autism. MJA 2005;182:354-360.

  42. Lord C, McGee JP. Educating Children with Autism. Comite para la intervención educativa de niños autistas. División de ciencias sociales y del comportamiento y Consejo Nacional de Investigación de los Estados Unidos. National Academy Press. Washington, DC, 2001.

  43. NIMH, NIH, DHHS (National Institute of Mental Health, National Institute of Health and, Department of Health and Human Services of the Unites States). Autism report for the Congress of Unites States. Washington DC. Febrero 2002.

  44. Belmonte MK, Yurgelun-Todd DA. Functional anatomy of impaired selective attention and compensatory processing in autism. Cogn Brain Res 2003;17:651-664.

  45. Manning-Courtney P, Brown J, Molloy A, Reinhold J, Murray D, Sorensen-Burnworth R, et al. Diagnosis and Treatment of Autism Spectrum Disorders. Curr Probl Pediatr Adolesc Health Care 2003;33:283-304.

  46. Baron-Cohen S, Allen J, Gillberg C. Can autism be detected at 18 months? The needle, the haystack, and the CHAT. Br J Psychiatry 1992;161:839-843.

  47. Baron-Cohen S, Cox A, Baird G, Swettenham J, Nightingale N, Morgan K, Drew A, Charman T. Psychological markers in the detection of autism in infancy in a large population. Br J Psychiatry 1996;168:158-163.

  48. Gilliam J. Gilliam Autism Rating Scale. Austin, Tex: Pro-ed; 1995.

  49. Stone WL, Hogan KL. A structured parent interview for identifying young children with autism. J Autism Dev Disord 1993;23:639-652.

  50. Siegel B. The Pervasive Developmental Disorder Screening Test-Stage. San Francisco: University of California; 2001.

  51. Lord C, Pickles A, McLennan J, Rutter M, Bregman J, Folstein S, et al. Diagnosing autism: analyses of data from the Autism Diagnostic Interview. J Autism Dev Disord 1997;27:501-517.

  52. Mesibov GB, Schopler E, Schaffer B, Michal N. Use of the childhood autism rating scale with autistic adolescents and adults. J Am Acad Child Adolesc Psychiatry 1989;28:538-541.

  53. Stone WL, Coonrod EE, Ousley OY. Brief report: screening tool for autism in two-year-olds (STAT): development and preliminary data. J Autism Dev Disord 2000;30:607-612.

  54. Lord C, Risi S, Lambrecht L, Cook EH Jr, Leventhal BL, DiLavore PC, et al. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated




2020     |     www.medigraphic.com